KOPRAN
Back to All Ratios
|
KOPRAN Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 2.25 | 1.16 | 2.25 | 1.17 | 0.52 |
What is the latest EV/CE ratio of KOPRAN ?
Year | EV/CE |
---|---|
Mar2024 | 2.25 |
Mar2023 | 1.16 |
Mar2022 | 2.25 |
Mar2021 | 1.17 |
Mar2020 | 0.52 |
How is EV/CE of KOPRAN Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 2.25 | 93.97 | |
Mar2023 | 1.16 | -48.44 | |
Mar2022 | 2.25 | 92.31 | |
Mar2021 | 1.17 | 125.00 | |
Mar2020 | 0.52 | - |
Other Financial Ratios of KOPRAN
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹919.4 Cr | 0.2% | 7.4% | -24.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹438,778.0 Cr | 2.3% | 5.6% | 21.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,949.0 Cr | 1.5% | 4.2% | 51.2% | Stock Analytics | |
CIPLA | ₹123,222.0 Cr | 0% | 2.9% | 10% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,205.0 Cr | 0.6% | 0.9% | 23.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,707.7 Cr | 0.8% | 1.8% | -5.4% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 0.2% |
7.4% |
-24.5% |
SENSEX | 0.9% |
4.2% |
8.3% |
You may also like the below Video Courses